Rubicon Research Q1 profit jumps 95.61% to ₹85 crore
In short
Rubicon Research reported Q1 2026 net profit of ₹85 crore, almost doubling year on year, while revenue climbed to ₹534.3 crore. The reporting also says it bought 85% of Arinna Lifesciences for ₹175.917 crore. A profit figure is what remains after expenses, and revenue is the total money brought in before costs. This matters because strong quarterly growth can support investor interest, but the reporting does not say how much of the result came from the acquisition or from underlying business demand.
What the reporting says
Rubicon Research reported Q1 2026 net profit of ₹85 crore, up 95.61%, while revenue rose 51.6% to ₹534.3 crore, according to publisher summaries. The same reporting says the company acquired 85% of Arinna Lifesciences for ₹175.917 crore. The available material does not say how the acquisition will affect future earnings or whether the quarter’s growth was driven by that deal.
Why it matters
Rubicon Research’s Q1 2026 numbers show sharp growth in profit and revenue, and the company also expanded by acquiring 85% of Arinna Lifesciences for ₹175.917 crore. The immediate effect is a stronger earnings profile and a larger business footprint, but the source does not quantify the acquisition’s contribution. Shareholders and market watchers will likely focus on whether this pace of growth can continue.